Ontario Molecular Pathology Research Network

OMPRN is a province-wide network of pathologists, clinical laboratory scientists and cancer researchers collaborating to carry out high-quality cancer research with a clear potential for clinical impact.

We’re Passionate about Pathology

The mission of OMPRN is to enhance molecular pathology research capacity across Ontario through providing research project support, education and networking opportunities for pathologists, clinical laboratory scientists and cancer researchers wishing to improve their skills in molecular aspects of cancer.

Learn More

$4.6M

Awarded to pathology-led research projects since 2016

Research projects funded

Principal investigators funded across Ontario

Pathology trainees involved in research projects

Recent News

July, 2024 – Letter from the OMPRN Director

As the days get longer and hotter, and our thoughts turn to the lazier pleasures of the season, we at OMPRN also find our thoughts…

July, 2024 – Exploring Genetic Ancestry and Tumour Mutational Burden in Cancer Treatment: Insights from Dr. Alexander Gusev

In May 2024, the Ontario Molecular Pathology Research Network (OMPRN) hosted an enlightening webinar featuring Dr. Alexander (Sash…

July, 2024 – Connect and Inform: New Website and Social Media Plan Bolsters OMPRN Networking and Education Efforts

To strengthen engagement with the cancer research community and the public, OMPRN has launched a redesigned website and is also di…

July, 2024 – Events and announcements

Find out about upcoming OMPRN events and important announcements here.

Become a Member

OMPRN connects pathologists and molecular pathology researchers across Ontario. Become a member to access exclusive research, educational and networking resources.

Join OMPRN

OMPRN’s patient resources

OMPRN aims to meet the education needs of everyone, from budding researchers to patients and members of the greater patient community.

View all Patient Resources

OMPRN was established by the Ontario Institute for Cancer Research (OICR) as part of its 2016-2021 Strategic Plan. OMPRN is also part of OICR’s Adaptive Oncology (AO) Initiative.